Earth Science Tech Inc. (OTC: ETST) is reinforcing its position in the healthcare and technology sectors by leveraging its proprietary infrastructure and strategic investments in subsidiaries such as DOConsultations LLC and Las Villas Health Care Inc. The company is focusing on the rapidly evolving telehealth industry, which is projected to be valued at $251.5 billion by 2030, reflecting a compound annual growth rate (CAGR) of 11.3% between 2025 and 2030 (source).
In addition to telehealth, Earth Science Tech is capitalizing on the surging demand for peptide therapies, a market expected to reach $249 billion by 2033. The company’s success is built on its proprietary technology and IT infrastructure, which provide a significant competitive edge. By continuing to push innovative tech development and expand vertical integration, ETST aims to tap into markets that are projected to grow tremendously over the coming years.
As a strategic holding company, Earth Science Tech builds value by acquiring and actively managing operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and select consumer markets. Through its proprietary tech and deep understanding of the market, the company identifies unique opportunities and steadily grows its market share. The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST.
InvestorWire, a specialized communications platform, syndicated this press release. InvestorWire is part of the Dynamic Brand Portfolio @ IBN, which provides access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release distribution, social media distribution, and tailored corporate communications solutions. For more information, visit https://www.InvestorWire.com. Please see full terms of use and disclaimers on the InvestorWire website at https://www.InvestorWire.com/Disclaimer.
